Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial: Differential Response in Acute Heart Failure

BACKGROUND: Over the last 50 years, clinical trials of novel interventions for acute heart failure (AHF) have, with few exceptions, been neutral or shown harm. We hypothesize that this might be related to a differential response to pharmacological therapy. METHODS: We studied the magnitude of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Licette C. Y., Valente, Mattia A. E., Postmus, Douwe, O’Connor, Christopher M., Metra, Marco, Dittrich, Howard C., Ponikowski, Piotr, Teerlink, John R., Cotter, Gad, Davison, Beth, Cleland, John G. F., Givertz, Michael M., Bloomfield, Daniel M., van Veldhuisen, Dirk J., Hillege, Hans L., van der Meer, Peter, Voors, Adriaan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550531/
https://www.ncbi.nlm.nih.gov/pubmed/28656542
http://dx.doi.org/10.1007/s10557-017-6726-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550531/
https://www.ncbi.nlm.nih.gov/pubmed/28656542
http://dx.doi.org/10.1007/s10557-017-6726-1

Ejemplares similares